InFlectis BioScience IFB-088 enters phase-1 clinical trial
InFlectis BioScience SAS, a member of Atlanpole Biotherapies, a drug discovery company committed to the development of innovative therapeutics harnessing... View Article
Florence Hallouin joins the CEBR’s board
Atlanpole Biotherapies and CEBR The Annual CEBR (Council of European BioRegions) meeting was held from 22 to 23 March in... View Article
Franck Grimaud elected president of Atlanpole Biotherapies cluster
On 20 February 2018, Franck Grimaud, managing director of Valneva since 1999, was elected chairman of the Atlanpole Biotherapies western... View Article
Atlanpole Biotherapies presents its strategic priorities
At its annual meeting , the Atlanpole Biotherapies western France biocluster presented its 2017 business report and outlook for 2018.... View Article
Bioregate 2018 : Call for abstracts
Nature of expected abstracts This call will be opened for short talks, posters and pitchs. This last possibility is only... View Article
Valneva to Present on Lyme and Zika at the 18th World Vaccine Congress in Washington, D.C.
Presentations to feature progress on Lyme and Zika vaccine candidates Valneva SE (“Valneva” or “the Company”), a fully integrated, commercial... View Article
Valneva and its Single-Shot Vaccine Candidate against Chikungunya
Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Valneva SE, a fully integrated commercial... View Article
VitamFero announces that Clean Cells has created a cell bank for its Toxo KO vaccine strain
Following its recent industrial partnership signed with a world leader for animal health to develop its bovine neosporosis vaccine candidate,... View Article
BIOREGATE FORUM: 2ND EDITION
SAVE THE DATE: BIOREGATE FORUM 2018 Bioregate forum 2018, an international congress dedicated to regenerative medicine, will be held from 12... View Article
IHU CESTI: capitalising on research
Capitalising on research results is a vital step in the innovative strategy of IHU CESTI CESTI focuses on immune responses occurring... View Article